Resources Repository
-
ArticlePublication 2023Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration
The Consolidated Health Economic Evaluation Reporting Standards Value of Information (CHEERS-VOI) 2022 checklist aims to …
The Consolidated Health Economic Evaluation Reporting Standards Value of Information (CHEERS-VOI) 2022 checklist aims to standardize reporting of Value of Information (VOI) analyses conducted alongside economic evaluations, ensuring transparent, reproducible, and high-quality reporting. Developed through a Delphi study, the CHEERS-VOI checklist includes 33 items, with 7 modifications and 6 new reporting criteria, building upon the existing CHEERS statement. Delphi participants rated candidate items through three survey rounds, resulting in the final checklist. This checklist should…
Evidence Synthesis | Value of Information | Health/Medicine -
ArticlePublication 2020Perceptions of COVID-19 around the World
This study evaluates public risk perception of COVID-19 around the world in ten countries across …
This study evaluates public risk perception of COVID-19 around the world in ten countries across Europe, America, and Asia. They found that significant predictors of risk perception included personal experience with the virus, individualistic and prosocial values, hearing about the virus from friends and family, trust in government, science, and medical professionals, personal knowledge of government strategy, and personal and collective efficacy. Although there was substantial variability across cultures, individualistic worldviews, personal experience, prosocial values,…
Risk Analysis | Health/Medicine | Culture/Society | Decision Psychology | Preferences/Values | Infectious Diseases | Global -
ArticlePublication 2021Individual and Social Determinants of COVID-19 Vaccine Uptake
This article examined the individual, communication and social determinants associated with COVID-19 vaccine uptake using …
This article examined the individual, communication and social determinants associated with COVID-19 vaccine uptake using national survey data collected before vaccines were available in the U.S. Of note, individuals under the federal poverty level and racial and ethnic minorities were oversampled. Outcomes included the likelihood of vaccinating self and dependents (e.g., children). Independent variables included perceptions of risk, exposure to different media for COVID-19 news, political party identification, confidence in scientists and social determinants of…
Evidence Synthesis | Health/Medicine | Culture/Society | Health Outcomes | Infectious Diseases | Social Determinants | Policy/Regulation | Clinical Care | Science/Technology | North America -
ArticlePublication 2021COVID-19 Vaccine Hesitancy: The Five C's to Tackle Behavioral and Sociodemographic Factors
Reversing and mitigating the ongoing damage associated with the COVID-19 pandemic requires that 60-70% of …
Reversing and mitigating the ongoing damage associated with the COVID-19 pandemic requires that 60-70% of the world’s population needs to be vaccinated. This article acknowledges that hesitancy is one of the most substantial hurdles to vaccination uptake at levels that would achieve herd immunity. Authors define hesitancy as “a delay in acceptance or refusal despite availability.” Five factors are proposed to tackle vaccine hesitancy, referred to as the five “C’s”: Confidence (importance, safety and efficacy…
Evidence Synthesis | Health/Medicine | Culture/Society | Decision Psychology | Preferences/Values | Health Outcomes | Infectious Diseases | Social Determinants | Science/Technology | North America -
BookPublication 2015Methods for the Economic Evaluation of Health Care Programmes, 4th Edition
The 2015 edition of Methods for the Economic Evaluation of Health Care Programmes provides a …
The 2015 edition of Methods for the Economic Evaluation of Health Care Programmes provides a 'tool kit' for undertaking health economic evaluations. The report is aimed at researchers, health service professionals and policy makers without a formal economics background. The recommendations are based on the authors' own experiences and so are practical in nature. The book describes the challenges of allocating resources efficiently and fairly, including challenges in methodology and policy formation. Examples are provided.…
Evidence Synthesis | Value of Information | Health/Medicine | Preferences/Values | Priority Setting/Ethics | Costing Methods | Health Outcomes | Mathematical Models | Benefit-Cost Analysis | Cost-Effectiveness Analysis | Economics/Finance | Science/Technology | Global | North America | Europe -
BookPublication 2009Encyclopedia of Medical Decision Making
This encyclopedia addresses both prescriptive and descriptive decision making through a conceptual structure consisting of six …
This encyclopedia addresses both prescriptive and descriptive decision making through a conceptual structure consisting of six components of classical decision analysis. It includes articles that have been prepared by more than 200 contributors from around the world. The alphabetical organization of the encyclopedia facilitates access to information. A Reader’s Guide, organized by category of the decisionmaking process includes the following 7 components: Identification of the decision maker - in other words, who must choose. In general, there…
Evidence Synthesis | Value of Information | Health/Medicine | Decision Psychology | Preferences/Values | Costing Methods | Test Performance | Mathematical Models | Decision Analysis | Benefit-Cost Analysis | Cost-Effectiveness Analysis | Technology Assessment -
BookPublication 1996Cost-Effectiveness in Health and Medicine, 1st Edition
In 1993, the US Public Health Service convened a panel of 13 nongovernment scientists and …
In 1993, the US Public Health Service convened a panel of 13 nongovernment scientists and scholars with expertise in economics, clinical medicine, ethics, and statistics to review the state of cost-effectiveness analysis and to develop recommendations for its conduct and use in health and medicine. Publishing their results in 1996, they proposed the most explicit set of guidelines (together with their rationale) ever defined on the conduct of CEAs. The panel recommended analysts include a "reference-case"…
Evidence Synthesis | Value of Information | Health/Medicine | Preferences/Values | Priority Setting/Ethics | Costing Methods | Health Outcomes | Cost-Effectiveness Analysis | Health Systems | Policy/Regulation | Economics/Finance | North America -
ArticlePublication 2023Developing Criteria for Health Economic Quality Evaluation Tool
This study presents the development of a novel quality assessment tool for cost-effectiveness analyses (CEAs) …
This study presents the development of a novel quality assessment tool for cost-effectiveness analyses (CEAs) named the Criteria for Health Economic Quality Evaluation (CHEQUE). The tool introduces three major enhancements: differentiating methods and reporting quality, quantifying the relative importance of different quality attributes, and providing an accessible, web-based tool for usability. Methods involved defining 15 quality domains and identifying 72 quality attributes through a scoping review. Researchers and practitioners were surveyed using a best-worst scaling…
Evidence Synthesis | Health/Medicine | Cost-Effectiveness Analysis -
ArticlePublication 2023Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments
The study assessed the diversity of clinical trials informing assessments by the Institute for Clinical …
The study assessed the diversity of clinical trials informing assessments by the Institute for Clinical and Economic Review (ICER) over five years (2017-2021). It conducted a cross-sectional analysis of 208 pivotal trials across 31 conditions. Findings revealed inadequate representation of racial/ethnic minorities and older adults, with Blacks/African Americans, American Indians/Alaska Natives, and Hispanics/Latinos being notably underrepresented. Whites, Asians, and Native Hawaiian/Other Pacific Islanders were adequately represented. US-based trials better represented Blacks/African Americans and Hispanics/Latinos but…
Evidence Synthesis | Health/Medicine | Technology Assessment | North America